Archimed

CandidateSEC exempt reporting adviser· LyonARCHIMED.GROUP

ARCHIMED is a global investment firm focused on driving the sustainable development of healthcare industries.

In the firm's own words, from its website.

Reported fund assets
$7.6B
sum of its funds' Form ADV filings, last 30 months
New companies, 12 mo
1
Investment team
16
Latest vintage
2024
Contact decision makers
More
Ask DFX about thisView relationshipsFind contactsInvestments (53)Team (18)Funds
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

15 additional team members, 2 additional co-investors and affiliates, 66 additional investments, funds and LPs, 23 events, 31 verified contacts (30 professional url, 1 firm phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 company
    new in 12 months

    1 new company in the last 12 months.

    A firm writing cheques this quarter is one a founder can pitch now.

    Factfunding announcements, Form D, the firm's portfolio pageFor Founders, co-investorsInvestments →

People to know

View all people
  • Anthony Farias
    Partner
    Why: Partner: part of the investment decision
    Profile
  • Angie Kim
    Managing Director
    Why: Managing director
    Profile
  • Antoine Faguer
    Delegate Managing Director
    Why: Managing director
    Profile

Relationship network

96 connected entities1 observed round

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.

Reading the network
  • Sponsor
  • Company
  • Capital provider
  • Fund or vehicle
  • Person

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Archimed: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Archimed

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

53 companies on record, 1 new in 12 months
Investments on record
53 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Acti 6portfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
Ad Techportfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
Aliriportfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
Stated thesis versus observed behaviour
54 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech, climate
Stages
not stated or not yet read
Geography
asia, global, globally, middle east
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series d plus 100%
Stage at first entry
series d plus 100%
Industries, each company once
Healthcare services (1)
lead rate 100%follow-on rate 0%new companies, 12 months 1

Team

18 current, 2 departed
Decision makers
who to call first, and why; then everyone else by function
  • Anthony Farias · Partner
    Why this person: Partner: part of the investment decision; Named with investment responsibility; Confirmed current on the firm's own site 2026-10-01
    LinkedIn or profile link on file (firm website, their bio on the firm's website), confirmed 2026-10-01, confidence 90%
  • Angie Kim · Managing Director
    Why this person: Managing director; Named with investment responsibility; Confirmed current on the firm's own site 2026-10-01
    LinkedIn or profile link on file (firm website, their bio on the firm's website), confirmed 2026-10-01, confidence 90%
  • Antoine Faguer · Delegate Managing Director
    Why this person: Managing director; Named with investment responsibility; Confirmed current on the firm's own site 2026-10-01
    LinkedIn or profile link on file (firm website, their bio on the firm's website), confirmed 2026-10-01, confidence 90%

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. 3 with a route on file. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team
18 current, 2 departed
2 departed (kept with end dates)
  • Andre-Michel Ballester · Delegate Managing Director · Sep 1, 2018 to Mar 19, 2024 Inference
  • Benoit Adelus · Delegate Managing Director · Sep 1, 2018 to Mar 31, 2021 Inference
Contacts
1 firm phone, 30 professional url

1 firm phone, 30 professional url on record, each with its source. Values open with the complete profile.

Funds and LPs

19 vehicles, 1 LPs disclosed
Funds and vehicles
19 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
MED Platform II B FpciFund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$186M
Mar 31, 2026
2unknownunknown
Mpii Slp + Mpii BFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.5B
Mar 31, 2026
164unknownunknown
Mpii Coi Nmi SlpFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$869M
Mar 31, 2026
38unknownunknown
Limited partners
1 LPs, 1 disclosed commitments
Known LPs and allocators
1 relationship across the firm's funds, from public pensions and the allocator graph
AllocatorTypeFundAmountDateSource
Teachers' Retirement System of the State of IllinoisSTATE RETIREMENT SYSTEMArchiMed SAS at Archimed
amount not disclosed
reported as of Jun 2, 2025Fact Pension disclosure

Relationships across DFX

5 co-investors · on 2 other DFX graphs
Co-investors
5 counted from shared deals, for the whole firm
Across DFX and the capital chainon 2 other DFX graphs · 2 capital paths Show
Across DFX
  • The same institution is held on Allocators, Private Equity, matched by identifier. See which records
Across the graphs

Archimed is the same institution as 2 records in Allocators and Private Equity.

Allocators1Private Equity1

DFX found 2 relationships across 2 datasets

Which record it is in each graph, what it is called there, and how the two were matched.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Checking your plan…

Capital chain

Archimed sits on 2 traced paths of capital across the graphs.

Allocator commitments to a manager

DFX traced 2 paths of capital through this record

Every record on each path, what it committed or lent, and as of when.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.

Checking your plan…

Evidence and history

28 dated events, 57 observations from 3 sources
Timeline
28 dated events
  1. Mar 31, 2026
    MED Rise S.L.P. first reported on Form ADV by Archimed (Private Equity Fund), GAV $28,898,880
    Fund first reported on Form ADVFundsInferenceMED Rise S.L.P.Form ADV
  2. Mar 31, 2026
    MED Access S.L.P. first reported on Form ADV by Archimed (Private Equity Fund), GAV $185,533,146
    Fund first reported on Form ADVFundsInferenceMED Access S.L.P.Form ADV
  3. Mar 31, 2026
    Mpii Coi Zimvie first reported on Form ADV by Archimed (Private Equity Fund), GAV $212,979,863
    Fund first reported on Form ADVFundsInferenceMpii Coi ZimvieForm ADV
  4. Mar 31, 2026
    MED Bio first reported on Form ADV by Archimed (Private Equity Fund), GAV $156,117,181
    Fund first reported on Form ADVFundsInferenceMED BioForm ADV
  5. Mar 31, 2026
    Mpii Coi Jeisys first reported on Form ADV by Archimed (Private Equity Fund), GAV $148,596,118
    Fund first reported on Form ADVFundsInferenceMpii Coi JeisysForm ADV
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 31, 2026 · 18 private fundsShow
Headquarters
Lyon, Franceadviserinfo.sec.gov
Office address
unknownadviserinfo.sec.gov
Business phone
unknownadviserinfo.sec.gov
Website
ARCHIMED.GROUP
SEC adviser type
Exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
Private fund adviseradviserinfo.sec.gov
Latest Form ADV
Mar 31, 2026
Private funds reported
18 (0 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$7.6Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
Zaizik (Delegate Managing Director), owns under 5%
Classification history
Every classification this record has carried1 on recordShow
  1. Sep 12, 2026
    Candidate (candidate, 50%)
    No sworn venture fact yet (name or round mention only)
Evidence
57 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedPrivate fund adviserMar 19, 2024FactForm ADV
SEC adviser typeExempt reporting adviserMar 31, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMar 19, 2024FactForm ADV
First Form ADV filing2018-07-20Mar 31, 2026FactForm ADV
First Form ADV filing2018-07-20Mar 19, 2024FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-29Sep 30, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-25Sep 26, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-23Sep 24, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-21Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-22Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2026-03-31Mar 31, 2026FactForm ADV
Latest Form ADV filing2024-03-19Mar 19, 2024FactForm ADV
Venture share of reported funds0Mar 31, 2026FactForm ADV
Venture share of reported funds0Mar 19, 2024FactForm ADV
Business phoneMar 19, 2024FactForm ADV
Contact page urlSep 30, 2026Factno URL
Contact page urlSep 16, 2026Factno URL
DescriptionSep 30, 2026Factno URL
DescriptionSep 16, 2026Factno URL
DescriptionSep 13, 2026Factno URL
HeadquartersLyon, FranceMar 19, 2024FactForm ADV
Office addressMar 19, 2024FactForm ADV
Legal formOther (specify)Mar 19, 2024FactForm ADV
Portfolio pageOct 1, 2026Factno URL
Portfolio pageSep 30, 2026Factno URL
Portfolio pageSep 16, 2026Factno URL
Portfolio pageSep 13, 2026Factno URL
Private funds reported18Mar 31, 2026FactForm ADV
Private funds reported13Mar 19, 2024FactForm ADV
Private fund gross assets (reported)$7.6BMar 31, 2026FactForm ADV
Private fund gross assets (reported)$7.0BMar 19, 2024FactForm ADV
Stated geographyAsia, global, globally, middle east
“geography words on the home page”
Sep 30, 2026Factno URL
Stated geographyAsia, global, globally, middle east
“geography words on the home page”
Sep 16, 2026Factno URL
Stated geographyAsia, global, globally, middle east
“geography words on the home page”
Sep 13, 2026Factno URL
Stated sectorsHealthcare, biotech, climate
“sector words on the home page”
Sep 30, 2026Factno URL
Stated sectorsHealthcare, biotech, climate
“sector words on the home page”
Sep 16, 2026Factno URL
Stated sectorsHealthcare, biotech, climate
“sector words on the home page”
Sep 13, 2026Factno URL
Team pageSep 30, 2026Factno URL
Team pageSep 16, 2026Factno URL
Team pageSep 13, 2026Factno URL
Venture funds reported0Mar 31, 2026FactForm ADV
Venture funds reported0Mar 19, 2024FactForm ADV
WebsiteMar 19, 2024FactForm ADV
Site titleSep 30, 2026Factno URL
Site titleSep 16, 2026Factno URL
Site titleSep 13, 2026Factno URL
How this is scored
Scores, classification basis and filing advisersCandidate, candidateShow
Importance
29
moderate
Active deployment
29
moderate
Emerging
0
low
Freshness
100
high
CandidateSEC exempt reporting adviser

No sworn venture fact yet (name or round mention only)

The inputs behind each score
importance
gav: $0 · funds: 0 · people: 0.8 · investments: 0.64 · scale basis: Venture-typed funds only (Candidate): 0 funds, $0M of $7.6B reported · co investors: 0.28
active deployment
investments 12m: 0.13 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: 2026-08-19
emerging manager
fund count: 19 · reported gav: $7.6B · first adv filing: 2018-07-20 · years since first filing: 8.2

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Record history

2 dated events on the change ledger, latest event first
  • LP commitment disclosed
    2025-06-02source on record
  • Adviser's first ADV filing
    2018-07-20source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.